Electra Therapeutics files for IPO on Nasdaq, ticker ETRA
Electra Therapeutics filed a 424B4 prospectus for an initial public offering on the Nasdaq Global Select Market (ETRA). The company is offering 23,333,334 shares at $15.00 each for about $350.0 million gross proceeds (about $319.9 million net).